Oramed Pharmaceuticals ORMP Q4 2025 Annual earnings
Reported March 26, 2026 · After market close
EPS-$0.06Beat by $0.02
Revenue estimate$500.0K
EPS estimate-$0.08
Next report
Aug 13, 2026 (In 2 weeks)EPS estimate$0.43
Versus estimates
Revenue
Diluted EPS
Ask the moment Oramed Pharmaceuticals reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Oramed Pharmaceuticals report Q4 2025 earnings?
- Oramed Pharmaceuticals (ORMP) reported Q4 2025 earnings on March 26, 2026 after market close.
- What were Oramed Pharmaceuticals's Q4 2025 revenue and EPS?
- Oramed Pharmaceuticals reported eps of $-0.06 for Q4 2025.
- Did Oramed Pharmaceuticals beat estimates in Q4 2025?
- EPS beat the consensus estimate of $-0.08 by $0.02.
- Where can I find Oramed Pharmaceuticals's Q4 2025 SEC filings?
- You can read the 10-K periodic report (0001213900-26-034835) directly on SEC EDGAR. The filing index links above go to sec.gov.